COCH today
$6.79-$0.01 (-0.22%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourDescending Triangle
15 minLeaning Bullish
5 minExpanding
Daily trend turns down below $0.36
Key levels
Resistance$11.72
Resistance$7.41
Support$0.54
Latest news & SEC filings
LegalEnvoy Medical Meets Nasdaq Listing Rule Again
NewsDot AI's Envoy gets $8.5M New Jersey grant for shared electric vehicles
AnalystAnalyst Keeps Positive Rating on Envoy Medical, Sets $18 Target
EarningsEnvoy Medical Posts Q3 2026 Numbers
All COCH news →About Envoy Medical
Envoy Medical is a hearing health company that develops implantable hearing devices. Its Esteem device is an FDA-approved fully implanted active middle ear implant. The company is also developing the Acclaim CI, an investigational fully implanted cochlear implant that uses a middle ear sensor to capture sound. It operates in the United States and targets grown patients whose hearing loss is significant and nerve-related.
Based on the company's 10-K filed Mar 23, 2026.
Nasdaq · Healthcare
Envoy Medical, Inc. (COCH)
What Is the Price Target for COCH?
SEPT Low Target
$2.00
SEPT Mid Target
$2.25
SEPT High Target
$2.50
Analyst Consensus
$2.25
Is COCH a Buy or Sell Right Now?
Thesis
- •Revenue growing 7.1% YoY with SLOWING trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for COCH.
Start Free Trial →Is COCH Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$1.71
4
Moat Score
NONE
3/9
Piotroski Score
-56.0
Altman Z-Score
What Is Smart Money Doing with COCH?
Insider Signal
BUYING
12 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Lucas Brent T. | director officer | Buy | 32,856 | $20K | May 29, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →COCH Growth Story
Revenue YoY
7.1%
3yr Revenue CAGR
0.6%
EPS Growth YoY
17.45%
FCF Growth YoY
2.9%
Revenue Trend
SLOWING
Dark Pool Trades for COCH
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for COCH, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:36:07 | $6.92 | 1,100 | $$8K | SELL |
| 19:18:07 | $6.85 | 1,000 | $$7K | SELL |
| 18:07:11 | $6.75 | 2,000 | $$14K | BUY |
| 15:18:11 | $6.89 | 1,000 | $$7K | BUY |
| 18:05:18 | $7.01 | 1,800 | $$13K | SELL |
5 dark pool trades shown · $$47K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Envoy Medical, Inc. (COCH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →COCH — frequently asked questions
What is COCH stock price today?
Envoy Medical, Inc. (COCH) is at $6.79, down 0.22% (-$0.01) at the Nov 13, 2026 close.
Why is COCH stock moving today?
Latest COCH news — Nov 10, 2026: Envoy Medical Meets Nasdaq Listing Rule Again · Nov 9, 2026: Dot AI's Envoy gets $8.5M New Jersey grant for shared electric vehicles
What is the COCH price target?
The average analyst price target for COCH is $2.25, ranging from $2 to $3, based on 4 analysts. Latest: Lake Street initiates on Oct 6, 2026.
What do analysts rate COCH?
Analyst ratings for COCH: 0 Buy, 5 Hold, 0 Sell — consensus Hold.
Did COCH beat earnings?
COCH last reported on Aug 10, 2026: EPS -$0.07 vs -$0.08 expected — a beat of 12.5%.
Does COCH pay a dividend?
Yes. COCH's dividend yield is 14.04%.
What are COCH support and resistance levels?
Support: $0.54. Resistance: $7.41, $11.72.
What are insiders doing with COCH?
Insider activity: BUYING, 12 buys and 0 sells in the last 90 days.
What is the latest news on COCH?
Nov 10, 2026: Envoy Medical Meets Nasdaq Listing Rule Again · Nov 9, 2026: Dot AI's Envoy gets $8.5M New Jersey grant for shared electric vehicles · Nov 9, 2026: Analyst Keeps Positive Rating on Envoy Medical, Sets $18 Target